NO20003785L - Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon - Google Patents

Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon

Info

Publication number
NO20003785L
NO20003785L NO20003785A NO20003785A NO20003785L NO 20003785 L NO20003785 L NO 20003785L NO 20003785 A NO20003785 A NO 20003785A NO 20003785 A NO20003785 A NO 20003785A NO 20003785 L NO20003785 L NO 20003785L
Authority
NO
Norway
Prior art keywords
prevention
benzothiazole
trifluoromethoxy
therapy
amino
Prior art date
Application number
NO20003785A
Other languages
English (en)
Other versions
NO20003785D0 (no
NO327819B1 (no
Inventor
Andrees Bohme
Alain Boireau
Thierry Canton
Assunta Imperato
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20003785L publication Critical patent/NO20003785L/no
Publication of NO20003785D0 publication Critical patent/NO20003785D0/no
Publication of NO327819B1 publication Critical patent/NO327819B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20003785A 1998-02-06 2000-07-24 Anvendelse av riluzol eller et farmasoytisk akseptabelt salt derav NO327819B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801402A FR2774592B1 (fr) 1998-02-06 1998-02-06 Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
PCT/FR1999/000230 WO1999039710A1 (fr) 1998-02-06 1999-02-03 Application du 2-amino-6- trifluoromethoxy- benzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet

Publications (3)

Publication Number Publication Date
NO20003785L true NO20003785L (no) 2000-07-24
NO20003785D0 NO20003785D0 (no) 2000-07-24
NO327819B1 NO327819B1 (no) 2009-09-28

Family

ID=9522673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003785A NO327819B1 (no) 1998-02-06 2000-07-24 Anvendelse av riluzol eller et farmasoytisk akseptabelt salt derav

Country Status (18)

Country Link
US (1) US6245791B1 (no)
EP (1) EP1052989B1 (no)
JP (1) JP5127092B2 (no)
KR (1) KR100574378B1 (no)
AT (1) ATE245982T1 (no)
AU (1) AU761978B2 (no)
CA (1) CA2319686C (no)
DE (1) DE69909970T2 (no)
DK (1) DK1052989T3 (no)
EA (1) EA002676B1 (no)
ES (1) ES2199541T3 (no)
FR (1) FR2774592B1 (no)
IL (2) IL137608A0 (no)
NO (1) NO327819B1 (no)
NZ (1) NZ506124A (no)
PT (1) PT1052989E (no)
WO (1) WO1999039710A1 (no)
ZA (1) ZA99740B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60041365D1 (de) * 1999-06-04 2009-02-26 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Verwendung von Riluzol zur Behandlung Multipler Sklerose
KR20210024475A (ko) * 2018-05-27 2021-03-05 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. 질환 치료를 위한 릴루졸 경구 붕해 정제의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043070T3 (es) * 1988-12-15 1993-12-16 Rhone Poulenc Sante Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Also Published As

Publication number Publication date
JP2002502819A (ja) 2002-01-29
EA002676B1 (ru) 2002-08-29
IL137608A0 (en) 2001-07-24
DE69909970T2 (de) 2004-05-27
WO1999039710A1 (fr) 1999-08-12
KR100574378B1 (ko) 2006-04-26
DE69909970D1 (de) 2003-09-04
ES2199541T3 (es) 2004-02-16
FR2774592A1 (fr) 1999-08-13
PT1052989E (pt) 2003-12-31
NZ506124A (en) 2003-07-25
US6245791B1 (en) 2001-06-12
IL137608A (en) 2006-09-05
AU761978B2 (en) 2003-06-12
EA200000816A1 (ru) 2001-02-26
CA2319686A1 (fr) 1999-08-12
NO20003785D0 (no) 2000-07-24
EP1052989A1 (fr) 2000-11-22
CA2319686C (fr) 2009-06-23
AU2171199A (en) 1999-08-23
FR2774592B1 (fr) 2000-03-17
ATE245982T1 (de) 2003-08-15
NO327819B1 (no) 2009-09-28
EP1052989B1 (fr) 2003-07-30
KR20010040671A (ko) 2001-05-15
ZA99740B (en) 1999-08-02
JP5127092B2 (ja) 2013-01-23
DK1052989T3 (da) 2003-11-17

Similar Documents

Publication Publication Date Title
BR0109703A (pt) Derivados de piperazina
GB0225475D0 (en) Therapeutic agents
AP2005003350A0 (en) 3-(3,5-dioxo-4,5-dihydro-3H-(1,2,4) triazin-2-yl)-benzamide derivatives as p2X7 -inhibitors for the treatment of inflammatory diseases.
WO2005021495A3 (en) Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
NO20005290D0 (no) Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
FI974640A0 (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
DE69512310T2 (de) Glukopyranosid-Benzothiophene
NO20003785D0 (no) Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon
DK1183046T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
SV2001000202A (es) Uso de (-)-5-ceto-2-n,n-d1-n-propilamino-tetrahidrotetralina para el tratamiento del mal de parkinson
UY26405A1 (es) Método para tratar el mal de parkinson a través de la administración de (-)-5-ceto-2-n,n-d1-n-propilamino-tetrahidrotetralina.
ECSP003725A (es) Metodo para tratar el mal de parkinson a travez de la administracion de (-) -5- ceto-2-n, n-d1-n-propilamino-tetrahidrotetralina
UY26638A1 (es) Nuevos derivados de piperazina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees